The Net Income for EXACT Sciences is detailed below, including the formula and its most recent reported level. The displayed value tracks the most recently filed financial data. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Net Income
=
(Rev + Gain)
-
(Exp + Loss)
=
-207.95 M
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales. The disclosed Net Income for EXACT Sciences corresponds to the current reporting dataset. The data originates from publicly accessible accounting records.
Latest EXACT Sciences' Net Loss Growth Pattern
Net Loss for EXACT Sciences over 15 annual periods follows in the chart below. Year-to-year shifts within a slightly volatile series are common for this type of metric. Reviewing the full arc helps distinguish one-time events from sustained directional shifts. Tracking the rate of change rather than the level itself can surface turning points earlier. Steeper segments in EXACT Sciences' Net Loss chart indicate periods of accelerated change.
All values are based on reported financial data and presented for reference.
Net Income
Timeline
Net Loss Trend Statistics
Arithmetic Mean
-280,054,321
Coefficient Of Variation
-107.03
Mean Deviation
229,573,614
Median
-175,149,000
Standard Deviation
299,736,036
Sample Variance
89841.7T
Range
1B
R-Value
-0.60
Mean Square Error
61766.7T
R-Squared
0.36
Significance
0.01
Slope
-35,388,813
Total Sum of Squares
1437467.1T
EXACT Sciences Net Loss History
2026
-218.3 M
2025
-207.9 M
2024
-1 B
2023
-204.1 M
2022
-623.5 M
2021
-595.6 M
2020
-823.6 M
2019
-213.1 M
2018
-175.1 M
2017
-114.4 M
2016
-167.2 M
2015
-157.8 M
2014
-100 M
2013
-46.5 M
2012
-52.4 M
Net Income Driver Correlations
Building a solid financial model for EXACT Sciences starts with understanding how Net Income relates to other key accounts. Because EXACT Sciences' accounts do not operate independently, changes in Net Income typically affect other financial line items.
Accumulated Other Comprehensive Income is projected to change by approximately 4.76% year over year. For the prior annual period, Accumulated Other Comprehensive Income came in at 2.36 Million.
EXACT Sciences reports Net Income of -207.95 Million, placing it 160.93% below the Biotechnology sector average and 220.12% below the Health Care industry average. The net income for all United States stocks sits 136.42% above EXACT Sciences's figure.
Fundamental Drivers Relationships
Peer multiple analysis evaluates EXACT Sciences's pricing efficiency within its industry. You can analyze the relationship between different fundamental ratios across EXACT Sciences competition to find correlations between indicators driving EXACT Sciences's intrinsic value. More Info.
EXACT Sciences maintains a fifth standing in net income relative to competitors. It is rated below average in return on asset relative to competitors . Comparative financial data indicate that Net Loss is shifting by roughly 4.76%. A year ago, EXACT Sciences reported Net Loss at -207.95 Million. Valuation multiples such as P/E, P/B, and P/S compare EXACT Sciences to peer earnings performance.
Net Income Peer Comparison
Peer comparison on Net Income is one of the most widely used methods for evaluating EXACT Sciences relative to competitors. By comparing EXACT Sciences' Net Income against peers, investors can detect undervalued opportunities in the group.
EXACT Sciences is currently under evaluation in net income relative to competitors.
Institutional Holders
Institutional Holdings refers to the ownership stake in EXACT Sciences held by large financial organizations. These institutions often accumulate significant blocks of EXACT Sciences' shares, giving them meaningful voting power.
An assessment of EXACT Sciences's core fundamentals focuses on profitability, capital efficiency, and funding structure. The company is currently operating at a loss. Overall market capitalization tier is large-cap. For this reporting period, EXACT Sciences reflects revenue of 3.25 B, EPS loss of 1.1, negative operating margin of 9.28%, which helps anchor the current financial discussion.
For EXACT Sciences, this section uses periodic company reporting and market reference feeds and standardizes the results for cross-period comparison. Intraday timing differences may exist. Reported income, balance-sheet, and cash-flow fields adhere to GAAP or IFRS presentation rules.